Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 7 Lymphoma, Follicular 6 Leukemia, Biphenotypic, Acute 6 Leukemia 6 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Large-Cell, Immunoblastic 3 Leukemia, Myeloid, Acute 3 Burkitt Lymphoma 3 Prostatic Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Multiple Myeloma 2 Lymphohistiocytosis, Hemophagocytic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Graft vs Host Disease 2 Epstein-Barr Virus Infections 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia, Pneumocystis 1 Pneumonia 1 Pain 1 Neurotoxicity Syndromes 1 Neuroma, Acoustic 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Radiotherapy 8 Zoledronic Acid 7 Fentanyl 7 nabiximols 6 Morphine 6 Ibandronic Acid 6 Ketamine 5 Hydromorphone 5 Analgesia 5 Acetaminophen 5 Tapentadol 4 Oxycodone 4 Acupuncture Therapy 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Duloxetine Hydrochloride 2 Docetaxel 2 Calcium 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 strontium chloride 1 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Methylprednisolone × Clear all

NCT00676936 2020-09-01

Corticosteroids for Cancer Pain

Norwegian University of Science and Technology

Phase 3 Completed

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡